Angiocrine Bioscience, Inc.

Total Awards: 
3
Award Value: 
$14,989,696
Institution type: 
For profit
Short Name: 
Angiocrine
  • Share
  • Print
  • PDF version

Awards to the Institution

Program Investigator Award Title Award Value
Late Stage Preclinical Projects Paul Finnegan Development of AB-110: genetically-modified endothelial cells plus expanded cord blood hematopoietic stem cells as a transplantation therapy $3,797,117
Clinical Trial Stage Projects Paul Finnegan AB-110-001 Phase 1b Trial and Related Activities to Support Clinical Development of AB-110 $5,000,000
Clinical Trial Stage Projects Edward Kavalerchik AB-205-001 Phase 1b Trial and Related Activities to Support Clinical Development of AB-205 $6,192,579
Total:
$14,989,696.00
Icon for XLSX export